LU87335A1 - Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments - Google Patents

Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments

Info

Publication number
LU87335A1
LU87335A1 LU87335A LU87335A LU87335A1 LU 87335 A1 LU87335 A1 LU 87335A1 LU 87335 A LU87335 A LU 87335A LU 87335 A LU87335 A LU 87335A LU 87335 A1 LU87335 A1 LU 87335A1
Authority
LU
Luxembourg
Prior art keywords
water
fatty acids
drug solubilizers
soluble monoesters
monoesters
Prior art date
Application number
LU87335A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87335A1 publication Critical patent/LU87335A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU87335A 1987-09-15 1988-09-12 Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments LU87335A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (1)

Publication Number Publication Date
LU87335A1 true LU87335A1 (fr) 1989-04-06

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87335A LU87335A1 (fr) 1987-09-15 1988-09-12 Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments

Country Status (24)

Country Link
JP (1) JP3090666B2 (no)
KR (1) KR0131084B1 (no)
AT (1) AT395819B (no)
AU (1) AU628787B2 (no)
BE (1) BE1001204A5 (no)
CA (1) CA1338775C (no)
CH (1) CH683672A5 (no)
DK (1) DK175132B1 (no)
ES (1) ES2012118A6 (no)
FI (1) FI94837C (no)
FR (1) FR2620336B1 (no)
GB (1) GB2209671B (no)
GR (1) GR1002243B (no)
HU (1) HU205010B (no)
IE (1) IE61195B1 (no)
IL (1) IL87746A (no)
IT (1) IT1224886B (no)
LU (1) LU87335A1 (no)
MY (1) MY103769A (no)
NL (1) NL195094C (no)
NO (1) NO179434C (no)
NZ (1) NZ226163A (no)
PT (1) PT88492B (no)
SE (1) SE503279C2 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GR1000466B (el) * 1989-01-28 1992-07-30 Sandoz Ag Μεθοδος παρασκευης νεων φαρμακευτικων μορφων κυκλοσπορινης.
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DK1033128T4 (da) 1993-09-28 2012-03-19 Scherer Gmbh R P Blød gelatinekapselfremstilling
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AU2003267747A1 (en) * 2003-10-14 2005-05-05 Ramesh Varada Bapat Sterile gelling agents
JP5422871B2 (ja) * 2006-10-24 2014-02-19 不二製油株式会社 イソフラボン類組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (no) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (no) * 1966-11-22 1968-06-21
BE787842A (fr) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd Procede de preparation d'une suspension aqueuse de cristaux stables du type non beta d'esters d'acides gras superieurs du chloramphenicol
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤

Also Published As

Publication number Publication date
GR880100602A (el) 1989-06-22
IT1224886B (it) 1990-10-24
FI884192A0 (fi) 1988-09-13
FI94837B (fi) 1995-07-31
IE882772L (en) 1989-03-15
DK175132B1 (da) 2004-06-14
HUT49494A (en) 1989-10-30
KR890004694A (ko) 1989-05-09
CH683672A5 (de) 1994-04-29
HU205010B (en) 1992-03-30
IL87746A0 (en) 1989-02-28
IL87746A (en) 1992-07-15
BE1001204A5 (fr) 1989-08-16
JP3090666B2 (ja) 2000-09-25
IT8848349A0 (it) 1988-09-14
AT395819B (de) 1993-03-25
GB2209671B (en) 1991-11-13
FR2620336A1 (fr) 1989-03-17
NL8802275A (nl) 1989-04-03
GR1002243B (en) 1996-04-22
AU2217288A (en) 1989-04-27
MY103769A (en) 1993-09-30
JPH01151526A (ja) 1989-06-14
AU628787B2 (en) 1992-09-24
DK511188D0 (da) 1988-09-14
ATA224988A (de) 1992-08-15
NO179434C (no) 1996-10-09
ES2012118A6 (es) 1990-03-01
CA1338775C (en) 1996-12-10
SE503279C2 (sv) 1996-05-13
KR0131084B1 (ko) 1998-04-17
NO179434B (no) 1996-07-01
FI884192A (fi) 1989-03-16
SE8803221L (sv) 1989-03-16
DK511188A (da) 1989-03-16
NL195094C (nl) 2003-12-17
SE8803221D0 (sv) 1988-09-13
GB8821443D0 (en) 1988-10-12
FR2620336B1 (fr) 1991-10-25
GB2209671A (en) 1989-05-24
PT88492B (pt) 1993-03-31
NO884052L (no) 1989-03-16
PT88492A (pt) 1988-10-01
NZ226163A (en) 1991-08-27
IE61195B1 (en) 1994-10-19
NO884052D0 (no) 1988-09-13
FI94837C (fi) 1995-11-10

Similar Documents

Publication Publication Date Title
FR2620336B1 (fr) Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments
AU7194691A (en) Therapeutic use of indole-3-yl-carboxylic acid endo-8- methyl-8-aza-bicyclo(3,2,1)oct-3-yl ester
AU7119687A (en) Fungicidal acrylic acid derivatives and intermediates
FR2729307B1 (fr) Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
NO171296C (no) Kopling til aa forbinde slanger for medisinske formaal
IL83919A0 (en) Preparation of benzoic acid derivatives
AU609034B2 (en) Fungicidal acrylic acid derivatives and intermediates
NO873923L (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
FR2647445B1 (fr) Acides n-carboalkyloxy amino-11 undecanoiques et leurs esters, leurs procedes de preparation et leur utilisation en tant qu'agents epaississants
AU8680691A (en) Intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2608159B1 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments
IT1211673B (it) Procedimento di preparazione di esteri di acidi carbossilici insaturi
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
BE893324A (fr) Preparation d'esters d'acides carboxyliques
NO933016D0 (no) Fremgangsmaate for sikker administrering av fettsyre
TR24836A (tr) PIRIDIN KARBOKSILIK ASIT TüREVLERININ HAZIRLANMASI ICIN PROSES
FR2650290B1 (fr) Compositions polysulfurees de corps gras insatures? et/ou d'esters d'acides (poly) insatures, et eventuellement d'olefines, leur preparation et leur utilisation
FR2535322B1 (fr) Preparation d'acides aminocyclopentaniques
TR23881A (tr) Poliakrilonitrilden n-suelfometil akrilamit akrilik asit terpolimerlerinin hazirlanis yoentemi
IT1216806B (it) Esteri di acidi alchilpoliossialchi lencarbossilici, loropreparazione eloro impiego come tensioattivi
NO933017D0 (no) Fremgangsmaate for sikker administrering av fettsyre
GR3000552T3 (en) Use of 7-chloroquinoline-8-carboxylic acids for influencing the development of crops
IL82670A0 (en) Preparation of oxetane-3-carboxylic acids
FR2696467B1 (fr) Procédé de préparation de monoesters d'acides gras du D-fructose et leur utilisation dans les domaines cosmétique, bucco-dentaire, pharmaceutique et alimentaire.
IT8648672A0 (it) Procedimento per la preparazione dell'estere etilico dell'acido apovincaminico